《新股消息》燃料電池系統製造商億華通科技通過上市聆訊
中國領先的燃料電池系統製造商北京億華通科技通過上市聆訊。根據灼識諮詢報告,按2021年燃料電池系統總銷售功率計算,億華通在中國燃料電池系統市場排名第一,市場份額為27.8%。
公司的收入主要來自燃料電池系統銷售;燃料電池部件銷售;及提供技術開發服務。截至2022年6月30日止六個月收入2.69億人民幣,按年增1.28倍。不過,公司自2020年起錄得淨虧損,並預期至少在2025年之前仍會繼續錄得淨虧損。
億華通於2016年在新三板掛牌上市並成功累計股權融資7.9億元人民幣。於2020年8月登陸上交所科創板並成功累計融資15.5億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.